ASPH
Summary: This gene is thought to play an important role in calcium homeostasis. The gene is expressed from two promoters and undergoes extensive alternative splicing. The encoded set of proteins share varying amounts of overlap near their N-termini but have substantial variations in their C-terminal domains resulting in distinct functional properties. The longest isoforms (a and f) include a C-terminal Aspartyl/Asparaginyl beta-hydroxylase domain that hydroxylates aspartic acid or asparagine residues in the epidermal growth factor (EGF)-like domains of some proteins, including protein C, coagulation factors VII, IX, and X, and the complement factors C1R and C1S. Other isoforms differ primarily in the C-terminal sequence and lack the hydroxylase domain, and some have been localized to the endoplasmic and sarcoplasmic reticulum. Some of these isoforms are found in complexes with calsequestrin, triadin, and the ryanodine receptor, and have been shown to regulate calcium release from the sarcoplasmic reticulum. Some isoforms have been implicated in metastasis. [provided by RefSeq, Sep 2009].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
aspartate beta-hydroxylase | MIM:600582 | Ensembl:ENSG00000198363 | HGNC:HGNC:757 | PA25056 | 8q12.3 |
Gene Categories:
PROTEASEGO terms in ASPH
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IDA | GO:0005783 | endoplasmic reticulum |
CC | NAS | GO:0005789 | endoplasmic reticulum membrane |
CC | TAS | GO:0005789 | endoplasmic reticulum membrane |
CC | IDA | GO:0005886 | plasma membrane |
CC | IEA | GO:0016021 | integral component of membrane |
CC | IDA | GO:0032541 | cortical endoplasmic reticulum |
CC | IEA | GO:0033017 | sarcoplasmic reticulum membrane |
BP | TAS | GO:0006936 | muscle contraction |
BP | IEA | GO:0007389 | pattern specification process |
BP | IEA | GO:0008285 | negative regulation of cell proliferation |
BP | IEA | GO:0022900 | electron transport chain |
BP | IEA | GO:0031647 | regulation of protein stability |
BP | TAS | GO:0034220 | ion transmembrane transport |
BP | IEA | GO:0035108 | limb morphogenesis |
BP | IEA | GO:0042264 | peptidyl-aspartic acid hydroxylation |
BP | IDA | GO:0045862 | positive regulation of proteolysis |
BP | IEA | GO:0060021 | roof of mouth development |
BP | IEA | GO:0060325 | face morphogenesis |
BP | IDA | GO:0097202 | activation of cysteine-type endopeptidase activity |
BP | IEA | GO:1901879 | regulation of protein depolymerization |
BP | TAS | GO:1903779 | regulation of cardiac conduction |
MF | IEA | GO:0004597 | peptide-aspartate beta-dioxygenase activity |
MF | TAS | GO:0005198 | structural molecule activity |
MF | NAS | GO:0005509 | calcium ion binding |
MF | IPI | GO:0005515 | protein binding |
MF | TAS | GO:0008307 | structural constituent of muscle |
MF | TAS | GO:0009055 | electron transfer activity |
Gene expression in normal tissue: ASPH
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ASPH
Database | Pathway ID | Pathway Des. |
---|---|---|
biocarta | hifpathway | hypoxia-inducible factor in the cardivascular system |
reactome | R-HSA-2672351 | Stimuli-sensing channels |
reactome | R-HSA-382551 | Transport of small molecules |
reactome | R-HSA-397014 | Muscle contraction |
reactome | R-HSA-5576891 | Cardiac conduction |
reactome | R-HSA-5578775 | Ion homeostasis |
reactome | R-HSA-983712 | Ion channel transport |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD329 | Merck60 | 3 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD367 | Ro 28-1675 | 2 |
iGMDRD147 | Prima-1 | 1 |
iGMDRD246 | NPC26 | 2 |
iGMDRD300 | Tozasertib | 3 |
iGMDRD213 | SMR000068650 | 3 |
iGMDRD231 | Importazole | 3 |
iGMDRD219 | Bax channel blocker | 4 |
iGMDRD57 | Chloropentafluorobenzene | 2 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD607 | Ubistatin B | 2 |
iGMDRD512 | nutlin 3 | 3 |
iGMDRD560 | MK-2206 | 2 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD506 | Fedratinib | 5 |
iGMDRD399 | Selumetinib | 1 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD268 | Cerulenin | 3 |
iGMDRD23 | Gossypol | 3 |
iGMDRD60 | Quinoclamine | 3 |
iGMDRD690 | PRIMA-1MET | 6 |
iGMDRD802 | 4-methylfasudil | 3 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD247 | Blebbistatin | 4 |
iGMDRD52 | Rotenone | 2 |
iGMDRD226 | ML006 | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 3 |
iGMDRD318 | PAC-1 | 5 |
iGMDRD441 | TW 37 | 3 |
iGMDRD152 | 179324-69-7 | 3 |
iGMDRD71 | Sparfosic acid | 3 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD380 | Pifithrin-alpha | 3 |
iGMDRD466 | Chaetocin | 2 |
iGMDRD425 | ERASTIN | 1 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD427 | ABT737 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ASPH